Harvard – Molecular motors, built from proteins, are a kind of transport service that keep cells functioning. They traffic essential chemical packages between the heart of the cell, the nucleus, and the cell periphery. In elongated cells such as neurons, this can be a big commute in cellular miles, equivalent to a person walking from Boston to Manhattan. The constant shuttling of materials by motors keeps cells alive and allows cells to move and divide, and talk to their neighbors.
It’s no surprise, then, that when these motors stop functioning, serious problems can result. In fact, defects in dynein-based transport have been linked to Lou Gehrig’s and Parkinson’s disease and the neurodevelopmental disease lissencephaly.
Nature – Molecular motors: A staggering giant
The protein dynein ‘walks’ along filaments to transport various cargoes within the cell. Two studies reveal that, unlike other motor proteins, dynein’s steps are not strictly coordinated.
To understand how this essential protein machine works, Reck-Peterson and colleagues decided to study the dynamics of motor movement on the nanoscale by developing protein engineering methods and then implementing single molecule imaging technologies.
First, they purified dynein motors, whose “legs” were tagged with fluorescent markers, and microtubules, long filaments that serve as dynein’s highway. Next, they put these components on a microscope slide and directly visualized dynein motors stepping along microtubule tracks.
“Dynein is critical for the function of every cell in our bodies,” said Reck-Peterson. “Deciphering the walking mechanism of this and other tiny machines may one day shed light on the molecular origins of certain diseases.”
If you liked this article, please give it a quick review on ycombinator or StumbleUpon. Thanks
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.